Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- SanBio Links Arms with Keio University on Alzheimer’s Drug Research
November 30, 2022
- No Direct Causal Link between Lecanemab and Death in Clinical Trial: Eisai
November 30, 2022
- KM Biologics to File COVID Jab in Japan Spring 2023: Official
November 29, 2022
- Kyowa Kirin Unit, Grunenthal Seal JV Deal for Established Medicines Biz
November 28, 2022
- Mediator Sees Potential for Turnaround in Nichi-Iko’s Restructuring Plan
November 28, 2022
- PeptiDream to Codevelop Lilly's Alzheimer’s Diagnostic Tauvid in Japan
November 25, 2022
- Opdivo Secures Top-Selling Title, Veklury Runner Up in July-September: IQVIA
November 25, 2022
- Shionogi Chief Defends Xocova Data, Eager to Prove Benefits in Clinical Settings
November 25, 2022
- AbbVie Japan Launches Maviret for Age 3 and Older
November 25, 2022
- Takeda’s Dengue Vaccine Bags Fast-Track Tag in US
November 25, 2022
- Fujifilm to Build Cell Culture Media Manufacturing Center in US
November 25, 2022
- Chugai to Transfer Bonviva Marketing Rights to Taisho
November 25, 2022
- FunPep’s Functional Peptide Fails in Japan PIII Study for Skin Ulcers
November 25, 2022
- Mitsubishi Tanabe, Sumitomo in Antibiotics Collabs with GARDP
November 25, 2022
- Eisai, Shimadzu Kick Off Blood Biomarker Research ahead of Lecanemab Launch
November 24, 2022
- Pfizer Seeks Breast Cancer Use for Avastin Biosimilar
November 24, 2022
- Japan Oncology Market Estimated to Expand 26% by 2030: Fuji Keizai
November 22, 2022
- Nucala Pediatric Form, Berinert SC, Upgraded Diquas Now Available
November 22, 2022
- Kyowa Kirin/MEI Deliver in Japan PII Trial for B-Cell Non-Hodgkin’s Lymphoma
November 21, 2022
- Alnylam’s Amvuttra Hits Japan Market for hATTR Amyloidosis
November 21, 2022
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…